Markets' Altitude Sickness Returns The Interest To The Dollar

Published 11/12/2020, 05:17 AM

The vaccine rally at the beginning of the week is showing more and more signs of exhaustion. The S&P 500 closed on Wednesday near its historic highs, but futures on the index on Thursday morning gave up the gains of the day before. Similarly, the Dow Jones pressured after touching all-time highs. The trend of selling at highs prevents stock indices from increasing growth.

SPX gave up the gains of the day before

The dynamics of Pfizer (NYSE:PFE) shares are indicative: On Monday, the price exceeded $41, making highs since mid-2019. However, by the end of trading, it had already returned to $38.4, the upper limit of the trading range since May. So as we can see, the markets have leveled out the importance of a breakthrough in vaccine development.
 
The markets reacted on Monday as if the coronavirus trend was over; however, further market dynamics make it seem that this is far from the case. Markets are experiencing altitude sickness at the peaks, as was the case earlier this year.
 
Dow Jones 30 and S&P 500, we see the same symptoms approaching the levels of 30,000 and 3600. Nasdaq 100 got its weakness near 12,000 and the German DAX30 at levels above 13,000, an important resistance area this year.

DAX knocked at resistance level near 13000
 
The foreign exchange market has been reacting all week to the risks of new restrictions, first by ignoring the optimism and now by the partial fixing of gains in stocks.
 
The euro was under pressure, which is unexpected when one assumes a general increase in demand for risk assets and hopes for an accelerated economic recovery. But this can easily be explained by the fact that politicians in the region are more inclined to impose restrictions to bring down the wave of infections. Under these circumstances, the euro found it challenging to develop growth, which caused EURUSD to drop from an area above 1.1900, where the pair was on Monday, to 1.1760.

EURUSD under pressure despite stock gains earlier this week
 
The strengthening of the dollar yesterday shifted to the pound and the renminbi. However, today we see a much broader growth of the US dollar in the foreign exchange market, pulling down the New Zealand dollar from 19-month highs at 0.69 and the Australian dollar from levels above 0.73.
 
It seems that analysts rushed into dismissing the dollar and celebrating the victory for stock markets from Biden's win. But, it may turn out that a more cautious approach by the new administration, combined with a long transition period, will make life more difficult for markets, slowing down incentives and increasing the traction of the dollar.

The FxPro Analyst Team

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.